Randomized, double‐blind, placebo‐controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder

Схожие документы

• Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Adults
  по: Matsuno, Kumi, et al.
  Опубликовано: (2017)
• A Double-Blind, Placebo-Controlled Study of Vortioxetine in the Treatment of Binge Eating Disorder
  по: Grant, Jon E., et al.
  Опубликовано: (2019)
• Efficacy and safety of lemborexant in adults with insomnia: comparing Japanese and non-Japanese subgroups from the global, phase 3, randomized, double-blind, placebo-controlled SUNRISE 2 study
  по: Inoue, Yuichi, et al.
  Опубликовано: (2021)
• Safety evaluation of the excessive intake of Bacillus subtilis C-3102 in healthy Japanese adults: A randomized, placebo-controlled, double-blind, parallel-group, comparison trial
  по: Hatanaka, Misaki, et al.
  Опубликовано: (2019)
• Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 2-week, randomized, double-blind, placebo-controlled study
  по: Vieta, Eduard, et al.
  Опубликовано: (2019)